Giuseppe Curigliano: I’ve witnessed the profound impact of ESMO on nurturing the young generation of medical oncologists
Giuseppe Curigliano shared a post by ESMO on X/Twitter:
“For 25 years, I’ve witnessed the profound impact of ESMO on nurturing the young generation of medical oncologists. Their unwavering support and inspiration are the pillars of our future in oncology. Let’s continue to empower their bright minds.”
Quoting ESMO’s post:
“Voting for the ESMO Presidency 2027-2028 is now open. Learn more about the candidates, Giuseppe Curigliano and Nadia Harbeck, and their vision for the Society. Cast your vote now.”
Source: Giuseppe Curigliano/X and ESMO/X
Giuseppe Curigliano, MD, PhD, is the Director of the Early Drug Development Division and co-chairs the Experimental Therapeutics Program at the European Institute of Oncology.
He is a member of the Department of Oncology and Hemato-Oncology’s steering committee at the University of Milan and serves on the Italian National Health Council, advising the Ministry of Health on cancer policy issues.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023